TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T29500	Adrenergic receptor alpha-1B	B7GBU4	N-(5-Bromoquinoxalin-6-yl)-4,5-dihydro-1,3-thiazol-2-amine	Investigative	44312037	C11H9BrN4S	309.19	C1CSC(=N1)NC2=C(C3=NC=CN=C3C=C2)Br	Ki = 60255.96 nM	Poor binder
T29500	Adrenergic receptor alpha-1B	BK7JE0	3-[2-[4-(4-Propan-2-ylphenyl)piperazin-1-yl]ethyl]-1H-[1]benzothiolo[3,2-d]pyrimidine-2,4-dione	Investigative	11144809	C25H28N4O2S	448.6	CC(C)C1=CC=C(C=C1)N2CCN(CC2)CCN3C(=O)C4=C(C5=CC=CC=C5S4)NC3=O	Ki = 100000 nM	Poor binder
T29500	Adrenergic receptor alpha-1B	BT6YX7	N-[(3Ar,7aS)-3a,4,5,6,7,7a-hexahydro-1H-benzimidazol-2-yl]-5-bromoquinoxalin-6-amine	Investigative	44311789	C15H16BrN5	346.22	C1CC[C@@H]2[C@H](C1)NC(=N2)NC3=C(C4=NC=CN=C4C=C3)Br	Ki = 104712.85 nM	Poor binder
T29500	Adrenergic receptor alpha-1B	BU56EC	N-(5-Bromoquinoxalin-6-yl)-4,5-dihydro-1,3-oxazol-2-amine	Investigative	44312198	C11H9BrN4O	293.12	C1COC(=N1)NC2=C(C3=NC=CN=C3C=C2)Br	Ki = 141253.75 nM	Poor binder
T29500	Adrenergic receptor alpha-1B	D05RWZ	2-fluoronorepinehprine	Investigative	6603724	C8H10FNO3	187.17	C1=C(C(=CC(=C1O)O)F)[C@H](CN)O	Ki = 134000 nM	Poor binder